Halozyme Therapeutics reported $12.23M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
DBV Technologies DBVT:US 16.34M 4.92M
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Amarin AMRN:US $ 116.31M 25.56M
Amgen AMGN:US $ 1256M 147M
Aptinyx Inc APTX:US $ 2.11M 354K
Baxter International BAX:US 1.28B 59M
Cara Therapeutics CARA:US $ 9.74M 4.15M
Cytokinetics CYTK:US $ 14.08M 5.76M
Eli Lilly And LLY:US $ 1659.3M 226M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Halozyme Therapeutics HALO:US $ 12.23M 10.97M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
Intra Cellular Therapies ITCI:US $ 10.75M 0.9M
Intrexon XON:US $ 2.67M 1.75M
JAZZ PHA JAZZ:US $ 74.16M 0.82M
Mannkind MNKD:US $ 7.82M 0.88M
Minerva Neurosciences NERV:US $ 1.52M 0.07M
Nektar Therapeutics NKTR:US $ 12.35M 0.27M
Peregrine Pharmaceuticals PPHM:US $ 30.46M 20.96M
Rigel Pharmaceuticals RIGL:US $ 2.15M 2.46M
Vanda Pharmaceuticals VNDA:US $ 5.55M 0.45M